IleusNCT00632801
Does Chewing Gum After Elective Laparoscopic Colectomy Surgery Decrease Ileus?
A study testing chewing gum in people with Ileus, run by State University of New York - Upstate Medical University at 1 site in United States.
Trial summary
The incidence of ileus after laparoscopic colectomy continues to pose complications for the patient, staff, and the healthcare system. Postoperative ileus remains a source of morbidity and a major determinant of length of stay after abdominal surgery. Read more about this study
- Who is it for?
- Ages 18 to 89 years
- Conditions the study is for
- Ileus
- What is being tested?
- chewing gum
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3 participants
- Where
- 1 siteUnited States
- Study dates
- Dec 2007to Dec 2011
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 89 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients admitted to one surgical unit (3-1) from November 1, 2007 to August 1, 2008 with a non- emergent laparoscopic colectomy.
Who cannot join
- All patients with:
- History of metastatic disease
- History of inflammatory bowel disease
- Abdominal radiation treatment
- Mint allergy (the gum is mint flavored)
- Dentures
Show all 10Show fewer
- Nasogastric tube drainage beyond the first postoperative morning
- More than one bowel anastomosis during this surgery
- Conversion to pen colectomy
- Admission to an ICI post-operatively.
Trial locations and contacts
1 site in 1 country.
About this study
The incidence of ileus after laparoscopic colectomy continues to pose complications for the patient, staff, and the healthcare system. Postoperative ileus remains a source of morbidity and a major determinant of length of stay after abdominal surgery. Clinicians have devised strategies that minimize postoperative ileus. Gum chewing, an inexpensive intervention, is theorized to activate the cephalic- vagal reflex and increase the production of gastrointestinal hormones associated with bowel motility. Four studies examining gum chewing as an intervention to prevent ileus were found. These relatively few studies have demonstrated inconsistencies. Because of the small sample size of the four studies and the inconsistencies of the results, there is not enough evidence to change practice. There are no indications of risks associated with gum chewing as an adjunct therapy along with standard postoperative interventions. The purpose of this prospective, randomized control study is to examine if chewing gum in adult patients after elective laparoscopic colectomy decreases ileus compared with standard post-operative care.
Patients will be randomized by weeks admitted and the patients in the gum chewing group (intervention group) will chew one stick of gum the first post-operative day, after the nasogastric tube is removed or if they patient does not have a nasogastric tube, with the head of bed elevated a minimum of 30 degrees for 30 minutes, three times a day at set intervals: 0900, 1400, and 2100. The gum will be kept in the Accudose cabinet and distributed by the medication nurse. The gum chewing regimen will continue until the first bowel movement. All patients in the non-intervention group will receive standard preoperative and postoperative regimens.
Patient demographics that will be collected include gender, age, current medical condition, pre-operative medications, type of surgery, operative duration in minutes, anesthesia duration in minutes, estimated operative blood loss, whether they had an epidural or a PCA, date and time nasogastric tube was discontinued, length of stay, date of discharge, complications, and whether or not they had an ileus. Patients (if appropriate) and nurses will be instructed on how to complete the bedside bowel record to the nearest hour.
Read the detailed description
Postoperative ileus remains a source of morbidity and a major determinant of length of stay after abdominal surgery. This unfortunate complication may certainly affect patient's satisfaction with their postoperative course. The postoperative care of a laparoscopic colectomy patient includes interventions that are evidence-based. Despite the evidence-based interventions, the incidence of ileus after laparoscopic colectomy continues to pose complications for the patient, staff, and the healthcare system. In the time period from January 1, 2006 to November 30, 2006 there were a total of 172 laparoscopic colectomies at St. Joseph's Hospital and 28 patients developed an ileus. Six percent of colectomy patients' recovery was altered by a prolonged ileus. This is comparably and slightly less then the National Veterans Affairs Surgical Quality Improvement Program's data for postoperative ileus of 7.5 % (Longo et al. 2000). However, the length of stay for patients with an ileus was 8.4 days greater then non ileus patients, with a significant increased cost per ileus patient of $15,422.86. Clinicians have devised strategies that minimize postoperative ileus. Adjunct therapies such as motility agents, early postoperative feeding regimens, and physical therapy have been tested in clinical trials, but are not routinely used because of their limited clinical efficacy (Matros, et al. 2006). Gum chewing, an inexpensive intervention, is theorized to activate the cephalic- vagal reflex, which is usually activated by food, and to increase the production of gastrointestinal hormones associated with bowel motility (Asao, et al, 2002).
Four studies examining gum chewing as an intervention to prevent ileus were found. These relatively few studies with a sample of postoperative abdominal surgical patients have demonstrated inconsistencies. Two studies found that the chewing gum group passed flatus and had a bowel movement sooner than the control group. One of these studies found a decreased length of stay. Two other randomized control studies found no statistical significance between the gum chewing and control groups as far as post-operative ileus or length of stay. Because of the small sample size of the four studies and the inconsistencies of the results, there is not enough evidence to change practice. The inexpensive method of gum chewing may be useful to decrease ileus in post-operative colectomy patients, which will decrease costs and length of stay. It could also decrease pain, emesis, and morbidity for patients. There are no indications of risks associated with gum chewing as an adjunct therapy along with standard postoperative interventions.
SPECIFIC OBJECTIVES: In adult elective laparoscopic colectomy patients does chewing gum decrease ileus compared with standard post-operative care? STUDY DESIGN: A prospective, randomized control design
SUBJECT SELECTION: (Include inclusion/exclusion criteria) All participants will be recruited at St. Joseph's Hospital. The sample will consist of all patients who are 18 years of age and older and are identified as adults on admission, and/or pre-admission for elective laparoscopic colectomy surgery. Inclusion criteria consist of all patients admitted to one surgical unit (3-1) from November 1, 2007 to August 1, 2008 with a non- emergent laparoscopic colectomy. Exclusion criteria consist of all patients with a history of metastatic disease, history of inflammatory bowel disease, abdominal radiation treatment, mint allergy (the gum is mint flavored), dentures, nasogastric tube drainage beyond the first postoperative morning, more then one bowel anastomosis during this surgery, conversion to pen colectomy, or admission to an ICI post-operatively.
STATISTICAL METHODS, DATA ANALYSIS AND INTERPRETATION: (Include the factors considered in determining an appropriate sample size) Data will be analyzed statistically. Descriptive statistics will be used to describe the entire sample, appropriate to the level of measurement of each. Independent t-tests for variables measured at ordinal or interval/ratio levels and chi-square for dichotomous variables will be used to compare the two groups on all demographic variables, hours since first flatus, and first bowel movement Analysis of co-variance may be used to statistically control for medical conditions found in the sample that were not excluded but could affect the findings.
STUDY PROCEDURES: (Describe all study methods chronologically. Distinguish clearly between treatment-related (standard care) and study-related procedures the subject will undergo).
NOTE: If the proposal includes genetic testing, some information about the genetic testing must be included. Please provide the following: 1. The type of study planned, 2. What genes are the investigators looking for, if known, 3. Why the genetic testing is being done (i.e., how it is relevant to the overall protocol), and 4. Where the work will be done.
After approval from St Joseph's IRB and SUNY Upstate's IRB, elective laparoscopic colectomy patients will be identified by the participating surgeons. At the time of preoperative instructions, a letter will be given or sent to the identified patient explaining the study (Appendix C). The day of pre-admission testing, the patient will be contacted by a study team member to review the study and will be asked to participate. If they agree, consent will be signed and the subjects will be assigned a number to ensure confidentiality.
The sample size of 50 will be randomized in block format, utilizing the weeks by number. The 38 weeks will be placed in a box; the first 19 weeks selected will be the gum chewing group, the second 19 weeks selected will be the non chewing group.
Each participant in the study will be educated to report to the nurse or self report on the bed side bowel report sheet the exact time to the hour that flatus is passed and the first bowel movement. The nursing staff on 3-1 will be instructed and monitored about documentation of gum chewing, first flatus to the nearest hour, and first bowel movement to the nearest hour. The data collection form will be completed. The length of the patients stay will be generated on discharge.
The patients in the gum chewing group (intervention group) will chew one stick of gum the first post-operative day, after the nasogastric tube is removed or if they patient does not have a nasogastric tube, with the head of bed elevated a minimum of 30 degrees for 30 minutes, three times a day at set intervals: 0900, 1400, and 2100. Sugar-free gum was used in all previous studies. Therefore, sugar free gum (Orbit Spearmint Sugarless Gum) will be used in this study. The gum will be kept in the Accudose cabinet and distributed by the medication nurse. The gum chewing regimen will continue until the first bowel movement. All patients in the non-intervention group will receive the standard preoperative and postoperative regimens. Patient demographics that will be collected include gender, age, current medical condition, pre-operative medications, type of surgery, operative duration in minutes, time left OR, anesthesia duration in minutes, estimated operative blood loss, whether the patient had an epidural or a PCA, date and time nasogastric tube was discontinued, length of stay, date of discharge, complications, and post-operative ileus. Patients and nurses will be instructed on how to complete the bedside bowel record to the nearest hour.
- Conditions
- Ileus
- Being tested
- chewing gum
- Keywords
- elective laparoscopic colectomy, chewing gum, ileus, post-operative care, colectomy
- Medical subject headings
- Ileus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
chewing gumOther
The patients in the gum chewing group (intervention group) will chew one stick of gum the first post-operative day, after the nasogastric tube is removed or if they patient does not have a nasogastric tube, with the head of bed elevated a minimum of 30 degrees for 30 minutes, three times a day at set intervals
| Study group | Role | What they receive |
|---|---|---|
| A | Other | Chewing gum or not Receives: Other: chewing gum |
What is being measured
The primary outcome is the main question the study is designed to answer.
Decrease ileus with intervention compared to standard post op care
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2008 (estimated)
- Study startDec 2007
- Primary completionDec 2011
- Study completionDec 2011
Why it stopped: Change in procedure nd medication used instead of gum
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for IleusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 3 participants (actual)
Sponsor and investigators
- Lead sponsor
- State University of New York - Upstate Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Melanie Kalman, State University of New York - Upstate Medical University
- Investigators
- Melanie Kalmanm, RN PhD, Principal investigator, SUNY UMU
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00632801
- Sponsor's protocol ID
- 5579
- Status last verified
- Dec 2014
- First submitted
- 3 Mar 2008
- Last updated
- 9 Dec 2014
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Dec 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does Chewing Gum After Elective Laparoscopic Colectomy Surgery Decrease Ileus?
- ClinicalTrials.gov ID
- NCT00632801
- Acronym / sponsor ID
- 5579
- Conditions
- Ileus
- Keywords
- elective laparoscopic colectomy, chewing gum, ileus, post-operative care, colectomy
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Change in procedure nd medication used instead of gum
- Enrolment
- 3 participants (actual)
- Lead sponsor
- State University of New York - Upstate Medical UniversityUniversity, hospital or other
- Study start
- Dec 2007
- Primary completion
- Dec 2011 (actual)
- Study completion
- Dec 2011 (actual)
- First posted
- 11 Mar 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The incidence of ileus after laparoscopic colectomy continues to pose complications for the patient, staff, and the healthcare system. Postoperative ileus remains a source of morbidity and a major determinant of length of stay after abdominal surgery. Clinicians have devised strategies that minimize postoperative ileus. Gum chewing, an inexpensive intervention, is theorized to activate the cephalic- vagal reflex and increase the production of gastrointestinal hormones associated with bowel motility. Four studies examining gum chewing as an intervention to prevent ileus were found. These relatively few studies have demonstrated inconsistencies. Because of the small sample size of the four studies and the inconsistencies of the results, there is not enough evidence to change practice. There are no indications of risks associated with gum chewing as an adjunct therapy along with standard postoperative interventions. The purpose of this prospective, randomized control study is to examine if chewing gum in adult patients after elective laparoscopic colectomy decreases ileus compared with standard post-operative care.
Patients will be randomized by weeks admitted and the patients in the gum chewing group (intervention group) will chew one stick of gum the first post-operative day, after the nasogastric tube is removed or if they patient does not have a nasogastric tube, with the head of bed elevated a minimum of 30 degrees for 30 minutes, three times a day at set intervals: 0900, 1400, and 2100. The gum will be kept in the Accudose cabinet and distributed by the medication nurse. The gum chewing regimen will continue until the first bowel movement. All patients in the non-intervention group will receive standard preoperative and postoperative regimens.
Patient demographics that will be collected include gender, age, current medical condition, pre-operative medications, type of surgery, operative duration in minutes, anesthesia duration in minutes, estimated operative blood loss, whether they had an epidural or a PCA, date and time nasogastric tube was discontinued, length of stay, date of discharge, complications, and whether or not they had an ileus. Patients (if appropriate) and nurses will be instructed on how to complete the bedside bowel record to the nearest hour.
Detailed description
Postoperative ileus remains a source of morbidity and a major determinant of length of stay after abdominal surgery. This unfortunate complication may certainly affect patient's satisfaction with their postoperative course. The postoperative care of a laparoscopic colectomy patient includes interventions that are evidence-based. Despite the evidence-based interventions, the incidence of ileus after laparoscopic colectomy continues to pose complications for the patient, staff, and the healthcare system. In the time period from January 1, 2006 to November 30, 2006 there were a total of 172 laparoscopic colectomies at St. Joseph's Hospital and 28 patients developed an ileus. Six percent of colectomy patients' recovery was altered by a prolonged ileus. This is comparably and slightly less then the National Veterans Affairs Surgical Quality Improvement Program's data for postoperative ileus of 7.5 % (Longo et al. 2000). However, the length of stay for patients with an ileus was 8.4 days greater then non ileus patients, with a significant increased cost per ileus patient of $15,422.86. Clinicians have devised strategies that minimize postoperative ileus. Adjunct therapies such as motility agents, early postoperative feeding regimens, and physical therapy have been tested in clinical trials, but are not routinely used because of their limited clinical efficacy (Matros, et al. 2006). Gum chewing, an inexpensive intervention, is theorized to activate the cephalic- vagal reflex, which is usually activated by food, and to increase the production of gastrointestinal hormones associated with bowel motility (Asao, et al, 2002).
Four studies examining gum chewing as an intervention to prevent ileus were found. These relatively few studies with a sample of postoperative abdominal surgical patients have demonstrated inconsistencies. Two studies found that the chewing gum group passed flatus and had a bowel movement sooner than the control group. One of these studies found a decreased length of stay. Two other randomized control studies found no statistical significance between the gum chewing and control groups as far as post-operative ileus or length of stay. Because of the small sample size of the four studies and the inconsistencies of the results, there is not enough evidence to change practice. The inexpensive method of gum chewing may be useful to decrease ileus in post-operative colectomy patients, which will decrease costs and length of stay. It could also decrease pain, emesis, and morbidity for patients. There are no indications of risks associated with gum chewing as an adjunct therapy along with standard postoperative interventions.
SPECIFIC OBJECTIVES: In adult elective laparoscopic colectomy patients does chewing gum decrease ileus compared with standard post-operative care? STUDY DESIGN: A prospective, randomized control design
SUBJECT SELECTION: (Include inclusion/exclusion criteria) All participants will be recruited at St. Joseph's Hospital. The sample will consist of all patients who are 18 years of age and older and are identified as adults on admission, and/or pre-admission for elective laparoscopic colectomy surgery. Inclusion criteria consist of all patients admitted to one surgical unit (3-1) from November 1, 2007 to August 1, 2008 with a non- emergent laparoscopic colectomy. Exclusion criteria consist of all patients with a history of metastatic disease, history of inflammatory bowel disease, abdominal radiation treatment, mint allergy (the gum is mint flavored), dentures, nasogastric tube drainage beyond the first postoperative morning, more then one bowel anastomosis during this surgery, conversion to pen colectomy, or admission to an ICI post-operatively.
STATISTICAL METHODS, DATA ANALYSIS AND INTERPRETATION: (Include the factors considered in determining an appropriate sample size) Data will be analyzed statistically. Descriptive statistics will be used to describe the entire sample, appropriate to the level of measurement of each. Independent t-tests for variables measured at ordinal or interval/ratio levels and chi-square for dichotomous variables will be used to compare the two groups on all demographic variables, hours since first flatus, and first bowel movement Analysis of co-variance may be used to statistically control for medical conditions found in the sample that were not excluded but could affect the findings.
STUDY PROCEDURES: (Describe all study methods chronologically. Distinguish clearly between treatment-related (standard care) and study-related procedures the subject will undergo).
NOTE: If the proposal includes genetic testing, some information about the genetic testing must be included. Please provide the following: 1. The type of study planned, 2. What genes are the investigators looking for, if known, 3. Why the genetic testing is being done (i.e., how it is relevant to the overall protocol), and 4. Where the work will be done.
After approval from St Joseph's IRB and SUNY Upstate's IRB, elective laparoscopic colectomy patients will be identified by the participating surgeons. At the time of preoperative instructions, a letter will be given or sent to the identified patient explaining the study (Appendix C). The day of pre-admission testing, the patient will be contacted by a study team member to review the study and will be asked to participate. If they agree, consent will be signed and the subjects will be assigned a number to ensure confidentiality.
The sample size of 50 will be randomized in block format, utilizing the weeks by number. The 38 weeks will be placed in a box; the first 19 weeks selected will be the gum chewing group, the second 19 weeks selected will be the non chewing group.
Each participant in the study will be educated to report to the nurse or self report on the bed side bowel report sheet the exact time to the hour that flatus is passed and the first bowel movement. The nursing staff on 3-1 will be instructed and monitored about documentation of gum chewing, first flatus to the nearest hour, and first bowel movement to the nearest hour. The data collection form will be completed. The length of the patients stay will be generated on discharge.
The patients in the gum chewing group (intervention group) will chew one stick of gum the first post-operative day, after the nasogastric tube is removed or if they patient does not have a nasogastric tube, with the head of bed elevated a minimum of 30 degrees for 30 minutes, three times a day at set intervals: 0900, 1400, and 2100. Sugar-free gum was used in all previous studies. Therefore, sugar free gum (Orbit Spearmint Sugarless Gum) will be used in this study. The gum will be kept in the Accudose cabinet and distributed by the medication nurse. The gum chewing regimen will continue until the first bowel movement. All patients in the non-intervention group will receive the standard preoperative and postoperative regimens. Patient demographics that will be collected include gender, age, current medical condition, pre-operative medications, type of surgery, operative duration in minutes, time left OR, anesthesia duration in minutes, estimated operative blood loss, whether the patient had an epidural or a PCA, date and time nasogastric tube was discontinued, length of stay, date of discharge, complications, and post-operative ileus. Patients and nurses will be instructed on how to complete the bedside bowel record to the nearest hour.
Study design
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| A | Other | Other: chewing gumChewing gum or not |
Who may qualify
- Ages
- 18 to 89 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All patients admitted to one surgical unit (3-1) from November 1, 2007 to August 1, 2008 with a non- emergent laparoscopic colectomy.
Key exclusion criteria (10 listed)
- History of metastatic disease
- History of inflammatory bowel disease
- Abdominal radiation treatment
- Mint allergy (the gum is mint flavored)
- Dentures
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| chewing gumThe patients in the gum chewing group (intervention group) will chew one stick of gum the first post-operative day, after the nasogastric tube is removed or if they patient does not have a nasogastric tube, with the head of bed elevated a minimum of 30 degrees for 30 minutes, three times a day at set intervals | Other | A |
Primary outcome
Decrease ileus with intervention compared to standard post op care
Time frame: 1 year
Results and safety
The study was stopped early (reason given: Change in procedure nd medication used instead of gum). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Dec 2014.
Related trials for Ileus
Recruiting
Rectus Sheath Catheters Following Midline Laparotomy
Acute Abdomen, Ileus
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingObservational study
At-Home Bowel Stimulation
Post-Operative Ileus (POI)
Recruiting
The Food Network Effect
Post Operative Patients
RecruitingObservational study
The Effect of Ostomy Care Education Applied With the Teach-Back Method to Ostomy-Opened Individuals on Self-Care Power, Ostomy Adjustment, and Anxiety
Ostomy - Ileostomy or Colostomy, Canser
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Melanie Kalmanm, RN PhD principal investigator
SUNY UMU
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing chewing gum in people with Ileus, run by State University of New York - Upstate Medical University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 9 Dec 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Change in procedure nd medication used instead of gum). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Decrease ileus with intervention compared to standard post op care (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2014.